The impact of corticosteroid use during anti-PD1 treatment.
Yifang Eva PanMan Yee MerlKatherine LinPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)
High-dose steroids for long durations during anti-PD1 therapy may be associated with poorer survival outcomes.